Session Information
Session Type: Abstract Submissions (ACR)
Colour Doppler sonography of the knee joint: A useful tool to discriminate Arthritis from Osteoarthritis ?
Background/Purpose:
To determine the diagnostic value of Colour Doppler ultrasound (CDUS) in patients with inflammatory arthritis (IA) versus osteoarthritis (OA) of the knee joint.
Methods:
Standardized CDUS examinations have been performed in 111 knee joints of 106 patients (70 female, 36 male) presenting with severe OA (n=72) or confirmed IA (n=39) of one or both knee joints, to determine the degree of synovial inflammation in a semiquantitative fashion. To definitely distinguish inflammatory from non-inflammatory disease, synovial fluid has been obtained from every patient within 24 hours after sonography and analyzed synovial fluids containing up to 1000 white blood cells (wbc)/ul were considered non-inflammatory, whereas 5000 or more wbc/ul have been classified as inflammatory, respectively.
Results:
The CDUS sum score of OA patients was determined at 3.3 (range 0-8). In contrast, IA patients exhibited significantly elevated synovitis scores at 5.3 (range 3-9) (p < 0.001). However, high synovial CDUS activity could be observed in OA patients sporadically. Therefore, there is no definitive CDUS threshold that clearly separates OA from IA patients.
Conclusion:
CDUS is a valuable instrument to assist clinicians in distinguishing OA from IA of the knee, but nevertheless should always interpreted within the clinical context.
Table 1: Mean CDUS scores of the patients with osteoarthritis vs. arthritis of the knee.
|
|
IA patients (n = 39)
|
suprapatellar |
0.14 (0-2) |
0.64 (0-2) |
infrapatellar |
0.14 (0-2) |
0.44 (0-2) |
medial longitudinal |
1.2 (0-3) |
2.0 (1-3) |
lateral longitudinal |
2.0 (0-3) |
2.3 (1-3) |
Total score |
3.3 (0-8) |
5.3 (3-9)** |
OA = Osteoarthritis, IA = inflammatory arthritis of the knee, ** (Chi square test: p value < 0.001).
Disclosure:
W. Hartung,
Abbott Immunology Pharmaceuticals,
5,
Pfizer Inc,
5;
N. Beitinger,
None;
B. P. Ehrenstein,
Abbott Immunology Pharmaceuticals,
5,
Pfizer Inc,
5,
Roche Pharmaceuticals,
5;
C. Lüring,
None;
J. Grifka,
None;
B. Schreiner,
None;
M. Müller,
None;
M. Fleck,
Abbott Immunology Pharmaceuticals,
5,
Roche Pharmaceuticals,
5,
Pfizer Inc,
5.
« Back to 2012 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/colour-doppler-sonography-of-the-knee-joint-a-useful-tool-to-discriminate-arthritis-from-osteoarthritis/